查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434729

抗菌藥物敏感性測試市場：按產品類型、方法、類型、應用、最終用戶分類 - 全球預測 2023-2030

Antimicrobial Susceptibility Testing Market by Product Type (Automated Products, Consumables, Manual Products), Method (Agar Dilution, Disks Diffusion, ETEST), Type, Application, End-User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2022年抗菌藥物敏感性測試市場規模為36.1億美元，2023年將達38.1億美元，2030年預計將達到56.7億美元，複合年成長率為5.80%。

全球抗菌藥物敏感性測試市場

主要市場統計
基準年[2022] 36.1億美元
預測年份 [2023] 38.1億美元
預測年份 [2030] 56.7億美元
複合年成長率（%） 5.80%
抗生素敏感性測試市場-IMG1

抗菌藥物敏感性測試 (AST) 確定抗生素和其他抗菌藥物對細菌、真菌和病毒等微生物的有效性。此測試方法是指導選擇適當的抗生素來治療感染疾病和監測抗藥性微生物菌株出現的重要工具。由於多種因素，該市場正在不斷成長，包括感染疾病率的上升、就地檢驗設施部署的增加以及對快速準確檢測抗生素抗藥性的需求激增。然而，影響 AST 市場擴張的挑戰包括與分子診斷設備和自動化系統等尖端技術相關的高成本，這限制了它們在小規模實驗室的採用。此外，新興國家獲得強大的醫療基礎設施的機會有限，研發資金不足，並且缺乏該領域的熟練專業人員。影響市場擴張的其他障礙包括影響市場准入和擴張努力的監管政策的區域差異。 。此外，診斷製造商、醫療保健專業人員、研究人員和製藥公司等相關人員可以簡化流程，同時加速 AST 技術的進步。此外，對感染疾病準確及時診斷的需求不斷成長，預計將為市場創造利潤豐厚的機會，特別是隨著疾病診斷測試技術的技術進步和新基因組鑑定方法的引入。

區域洞察

由於感染疾病發病率上升和醫療基礎設施先進，美洲和歐洲是全球抗菌藥物敏感性測試市場的重要地區。美國疾病管制與預防中心的美國醫療安全網路 (NHSN) 追蹤全國醫療機構的抗菌藥物抗藥性模式，確保收集高品質的資料，我們正在推動其引入。拉丁美洲在抗菌藥物敏感性測試 (AST) 領域取得了重大進展，巴西等國家採用並實施了臨床和實驗室標準研究所 (CLSI) 制定的指南。這項重要進展將有助於全球對抗抗菌素抗藥性的努力，並確保細菌感染疾病的有效治療選擇。此外，歐洲疾病預防與控制中心 (ECDC) 在透過歐洲抗菌藥物抗藥性監測網路 (EARS-Net) 追蹤整個歐洲的抗藥性模式方面發揮著至關重要的作用。由於人們對感染疾病的認知不斷提高、醫療保健支出不斷增加以及抗藥性微生物的出現，預計亞太地區 (APAC) 的市場將顯著成長。在亞太地區，中國、日本和印度是抗菌藥物敏感性測試的主要市場。鑑於這些國家感染疾病負擔沉重且人口眾多，預計對 AST 產品和服務的需求將會增加。此外，全球政府控制感染疾病的努力以及醫療基礎設施投資和資金籌措的增加預計將推動亞太地區的市場成長。

FPNV定位矩陣

FPNV定位矩陣對於評估抗菌藥物敏感性測試市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對抗菌藥物敏感性測試市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-抗菌藥物敏感性測試市場的市場規模和預測是多少？

2-抗菌藥物敏感性測試市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-抗菌藥物敏感性測試市場的技術趨勢和法律規範是什麼？

4-抗菌藥物敏感性測試市場主要供應商的市場佔有率為何？

5-進入抗菌藥物敏感性檢測市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 抗菌藥物敏感性測試在醫療決策中的重要性
      • 政府打擊和預防感染疾病的有利舉措
    • 抑制因素
      • 抗菌藥敏套件成本高且缺乏熟練的專業人員
    • 機會
      • 正在進行基於奈米顆粒的抗菌敏感性測試研究
      • 引進新基因組鑑定方法並推出抗菌藥物敏感性檢測套組
    • 任務
      • 關於產品召回的發生和抗菌藥物敏感性測試商業化的嚴格規定
  • 市場區隔分析
    • 產品類型：用於感染疾病早期診斷和治療的自動化工具和耗材的進步
    • 方法：發展提高測試準確性的定性 AST 技術
    • 類型：由於對侵襲性真菌感染疾病的認知提高，抗真菌藥物敏感性試驗取得重大進展
    • 應用：AST 在臨床診斷和藥物開發中的快速和極端利用
    • 最終用戶：AST 在醫院和診斷實驗室中廣泛使用
  • 市場趨勢分析
    • 在美洲開發抗菌藥物敏感性測試的政府計畫和重大研究工作。
    • 專注於抗生素敏感性測試的研發項目，以治療和診斷亞太地區高度流行的感染疾病
    • 用於抗生素敏感性測試的大量資金以及歐洲、中東和非洲地區監管機構的支持。
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章抗生素敏感性測試市場：依產品類型

  • 自動化產品
  • 消耗品
  • 手動產品
    • 最低抑菌濃度 (MIC) 試紙條
    • 感光盤
    • 磁化率板

第7章抗菌藥物敏感性測試市場：依方法

  • 瓊脂稀釋
  • 光碟的普及
  • ETEST
  • 基因型鑒定方法
  • 快速自動化方法

第8章抗生素敏感性測試市場：按類型

  • 抗菌藥物敏感性測試
  • 抗黴菌藥物敏感性試驗
  • 驅蟲藥敏感性試驗

第9章抗菌藥物敏感性測試市場：依應用分類

  • 臨床診斷
  • 藥物發現與開發
  • 流行病學

第10章抗菌藥物敏感性測試市場：依最終用戶分類

  • 合約研究組織
  • 醫院和診斷中心
  • 製藥和生物技術
  • 研究和學術機構

第11章美洲抗菌藥物敏感性測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區抗菌藥物敏感性測試市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲抗菌藥物敏感性測試市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 併購
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強
    • 投資、資金籌措
    • 獎項/獎勵/擴展

第15章競爭產品組合

  • 主要公司簡介
    • Accelerate Diagnostics, Inc.
    • Alifax Srl
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • BIOANALYSE Tﾄｱbbi Malz. San. ve Tic. Ltd. Sti.
    • BioMerieux SA
    • Biosafe Ltd.
    • Bruker Corporation
    • Creative Diagnostics
    • Danaher Corporation
    • ELITech Group SAS
    • Erba Lachema sro
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche AG
    • Genefluidics, Inc.
    • Himedia Laboratories Private Limited
    • INTEGRA Biosciences AG
    • Laboratorios Conda, SA
    • Launch Diagnostics Limited
    • Leading Biology, Inc.
    • Liofilchem Srl
    • Mast Group Ltd.
    • MP Biomedicals, LLC
    • Pfizer Inc.
    • Qiagen NV
    • QuantaMatrix Inc.
    • Rapid Test Methods Ltd.
    • Resistell AG
    • Synoptics Group
    • Thermo Fisher Scientific Inc.
    • Zhuhai DL Biotech Co., Ltd.
  • 主要產品系列

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-464C422F4BF4

[185 Pages Report] The Antimicrobial Susceptibility Testing Market size was estimated at USD 3.61 billion in 2022 and expected to reach USD 3.81 billion in 2023, at a CAGR 5.80% to reach USD 5.67 billion by 2030.

Global Antimicrobial Susceptibility Testing Market

KEY MARKET STATISTICS
Base Year [2022] USD 3.61 billion
Estimated Year [2023] USD 3.81 billion
Forecast Year [2030] USD 5.67 billion
CAGR (%) 5.80%
Antimicrobial Susceptibility Testing Market - IMG1

Antimicrobial susceptibility testing (AST) determines the effectiveness of antibiotics or other antimicrobial drugs against microorganisms such as bacteria, fungi, and viruses. This testing method is an essential tool for guiding the selection of appropriate antibiotics used in treating infectious diseases and monitoring the emergence of drug-resistant strains of microorganisms. The market is experiencing growth due to various factors, including the rising incidence of infectious disorders, the growing adoption of point-of-care testing facilities, and the surging demand for prompt and precise detection of antibiotic resistance. However, challenges affecting the expansion of the AST market comprise high costs associated with advanced technologies such as molecular diagnostics instruments or automated systems, limiting their adoption by small-scale laboratories. In addition, limited access to robust healthcare infrastructure in developing countries, insufficient funding for research and development (R&D), lack of skilled professionals in the field, and variation in regulatory policies among different regions affecting market entry or expansion efforts are the additional obstacles affecting the expansion of the market. Additionally building partnerships between industry stakeholders such as diagnostic manufacturers, healthcare providers researchers and pharmaceutical companies can streamline processes while driving advancements in AST technologies. Moreover, the increasing demand for accurate and timely diagnosis of infectious diseases is expected to create lucrative opportunities for the market, particularly with the technological advancement in disease diagnosis testing techniques and the introduction of new genomic identification methods.

Regional Insights

The Americas and Europe are significant regions in the global antimicrobial susceptibility testing market due to the rise in infectious diseases and advanced healthcare infrastructure. The Centers for Disease Control and Prevention's National Healthcare Safety Network (NHSN), which tracks antimicrobial resistance patterns in nationwide healthcare facilities, promotes AST adoption while ensuring high-quality data collection. In Latin America, significant progress is observed in the field of antimicrobial susceptibility testing (AST), with countries such as Brazil adopting and executing guidelines established by the Clinical & Laboratory Standards Institute (CLSI). This crucial development contributes to the global efforts in combating antimicrobial resistance, thereby ensuring effective treatment options for bacterial infections. Furthermore, the European Centre for Disease Prevention and Control (ECDC) plays a pivotal role in tracking resistance patterns across Europe through its European Antimicrobial Resistance Surveillance Network (EARS-Net). The Asia-Pacific (APAC) is expected to experience substantial growth in the market due to rising awareness about infectious diseases, increasing healthcare expenditure, and emerging drug-resistant microorganisms. China, Japan, and India are the major markets for antimicrobial susceptibility testing within the Asia-Pacific. These nations have a high burden of infectious diseases and a large population, which is expected to drive the demand for AST products and services. Moreover, government initiatives worldwide to control infectious diseases and rising investments & funding in healthcare infrastructure are expected to bolster the market growth in the APAC.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antimicrobial Susceptibility Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antimicrobial Susceptibility Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Susceptibility Testing Market, highlighting leading vendors and their innovative profiles. These include Accelerate Diagnostics, Inc., Alifax S.r.l., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BIOANALYSE Tıbbi Malz. San. ve Tic. Ltd. Sti., BioMerieux SA, Biosafe Ltd., Bruker Corporation, Creative Diagnostics, Danaher Corporation, ELITech Group SAS, Erba Lachema s.r.o., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genefluidics, Inc., Himedia Laboratories Private Limited, INTEGRA Biosciences AG, Laboratorios Conda, S.A., Launch Diagnostics Limited, Leading Biology, Inc., Liofilchem S.r.l., Mast Group Ltd., MP Biomedicals, LLC, Pfizer Inc., Qiagen N.V., QuantaMatrix Inc., Rapid Test Methods Ltd., Resistell AG, Synoptics Group, Thermo Fisher Scientific Inc., and Zhuhai DL Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Susceptibility Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Automated Products
    • Consumables
    • Manual Products
      • Minimum Inhibitory Concentration (MIC) Strips
      • Susceptibility Discs
      • Susceptibility Plates
  • Method
    • Agar Dilution
    • Disks Diffusion
    • ETEST
    • Genotyping Methods
    • Rapid Automation Method
  • Type
    • Antibacterial Susceptibility Testing
    • Antifungal Susceptibility Testing
    • Antiparasitic Susceptibility Testing
  • Application
    • Clinical Diagnostics
    • Drug Discovery & Development
    • Epidemiology
  • End-User
    • Contract Research Organizations
    • Hospital & Diagnostic Centers
    • Pharmaceutical & Biotechnology
    • Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antimicrobial Susceptibility Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antimicrobial Susceptibility Testing Market?

3. What are the technology trends and regulatory frameworks in the Antimicrobial Susceptibility Testing Market?

4. What is the market share of the leading vendors in the Antimicrobial Susceptibility Testing Market?

5. Which modes and strategic moves are suitable for entering the Antimicrobial Susceptibility Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antimicrobial Susceptibility Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Importance of antimicrobial susceptibility testing in medical decision-making
      • 5.1.1.2. Favorable government initiatives aiming to combat and prevent infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of antimicrobial susceptibility kits and lack of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research on nanoparticles-based antimicrobial susceptibility testing
      • 5.1.3.2. Introduction of new genomic identification methods and launch of antimicrobial susceptibility test kits
    • 5.1.4. Challenges
      • 5.1.4.1. Incidence of product recalls and strict regulations regarding antimicrobial susceptibility testing commercialization
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Advancement in the automated tools and consumables for early diagnosing and treatment of the infectious diseases
    • 5.2.2. Method: Development of qualitative AST techniques with increased accuracy of the tests
    • 5.2.3. Type: Significant advancements in antifungal susceptibility testing due to heightened awareness of invasive fungal infections
    • 5.2.4. Application: Rapid and extreme utilization of the AST in clinical diagnostics and drug discovery and development
    • 5.2.5. End-User: Extensive use of AST in hospitals and diagnostic laboratories
  • 5.3. Market Trend Analysis
    • 5.3.1. Government programs and significant research activities to develop antimicrobial susceptibility tests in the Americas.
    • 5.3.2. Emphasis on the antibiotic susceptibility testing research and development programmes to treat and diagnose highly prevalent communicable diseases in APAC
    • 5.3.3. Significant funding for antibiotic susceptibility testing and support from regulatory agencies in the EMEA region.
  • 5.4. Cumulative Impact of COVID-19
  • 5.5. Cumulative Impact of Russia-Ukraine Conflict
  • 5.6. Cumulative Impact of High Inflation
  • 5.7. Porter's Five Forces Analysis
    • 5.7.1. Threat of New Entrants
    • 5.7.2. Threat of Substitutes
    • 5.7.3. Bargaining Power of Customers
    • 5.7.4. Bargaining Power of Suppliers
    • 5.7.5. Industry Rivalry
  • 5.8. Value Chain & Critical Path Analysis
  • 5.9. Regulatory Framework

6. Antimicrobial Susceptibility Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Automated Products
  • 6.3. Consumables
  • 6.4. Manual Products
    • 6.5.1. Minimum Inhibitory Concentration (MIC) Strips
    • 6.5.2. Susceptibility Discs
    • 6.5.3. Susceptibility Plates

7. Antimicrobial Susceptibility Testing Market, by Method

  • 7.1. Introduction
  • 7.2. Agar Dilution
  • 7.3. Disks Diffusion
  • 7.4. ETEST
  • 7.5. Genotyping Methods
  • 7.6. Rapid Automation Method

8. Antimicrobial Susceptibility Testing Market, by Type

  • 8.1. Introduction
  • 8.2. Antibacterial Susceptibility Testing
  • 8.3. Antifungal Susceptibility Testing
  • 8.4. Antiparasitic Susceptibility Testing

9. Antimicrobial Susceptibility Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
  • 9.3. Drug Discovery & Development
  • 9.4. Epidemiology

10. Antimicrobial Susceptibility Testing Market, by End-User

  • 10.1. Introduction
  • 10.2. Contract Research Organizations
  • 10.3. Hospital & Diagnostic Centers
  • 10.4. Pharmaceutical & Biotechnology
  • 10.5. Research & Academic Institutes

11. Americas Antimicrobial Susceptibility Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Antimicrobial Susceptibility Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Antimicrobial Susceptibility Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player
    • 14.3.1. Merger & Acquisition
      • 14.3.1.1. Bio-Rad Acquires Curiosity Diagnostics
    • 14.3.2. Agreement, Collaboration, & Partnership
      • 14.3.2.1. JMI Laboratories and bioMerieux Enter Antimicrobial Resistance Diagnostics Partnership
      • 14.3.2.2. FASTinov Collaborates With Beckman Coulter Life Sciences To Bring Ultra-Rapid 2h-AST Disruptive Technology To Clinical Microbiology Laboratories
      • 14.3.2.3. BD Enters Commercial Collaboration With Accelerate Diagnostics
    • 14.3.3. New Product Launch & Enhancement
      • 14.3.3.1. Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
      • 14.3.3.2. Sysmex Launches World's First Point-of-Care Testing System in Europe to Detect Antimicrobial Susceptibility in Just 30 Minutes
    • 14.3.4. Investment & Funding
      • 14.3.4.1. Strathclyde spin-out Microplate dx secures GBP 2.5 million in funding
      • 14.3.4.2. Pattern Bioscience Secures USD 28.7 Million in Series C Financing
      • 14.3.4.3. Resistell raises CHF 8.5 million to complete clinical trials for antibiotic susceptibility testing
      • 14.3.4.4. Avails Medical, A Developer 0f Automated and Fully Electrical Antibiotic Susceptibility Testing (East) has Announced the Transition to The Next Phase of Its Carb-X Grant.
    • 14.3.5. Award, Recognition, & Expansion
      • 14.3.5.1. Gradientech Welcomes Investment From Commercial Partner
      • 14.3.5.2. bioMerieux's Submits Vitek Reveal to FDA for Clearance
      • 14.3.5.3. Selux Diagnostics Secures FDA Approval For Its Rapid Antibiotic Susceptibility Test
      • 14.3.5.4. FDA clears rapid antibiotic susceptibility test

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Accelerate Diagnostics, Inc.
    • 15.1.2. Alifax S.r.l.
    • 15.1.3. Becton, Dickinson and Company
    • 15.1.4. Bio-Rad Laboratories, Inc.
    • 15.1.5. BIOANALYSE Tıbbi Malz. San. ve Tic. Ltd. Sti.
    • 15.1.6. BioMerieux SA
    • 15.1.7. Biosafe Ltd.
    • 15.1.8. Bruker Corporation
    • 15.1.9. Creative Diagnostics
    • 15.1.10. Danaher Corporation
    • 15.1.11. ELITech Group SAS
    • 15.1.12. Erba Lachema s.r.o.
    • 15.1.13. Eurofins Scientific SE
    • 15.1.14. F. Hoffmann-La Roche AG
    • 15.1.15. Genefluidics, Inc.
    • 15.1.16. Himedia Laboratories Private Limited
    • 15.1.17. INTEGRA Biosciences AG
    • 15.1.18. Laboratorios Conda, S.A.
    • 15.1.19. Launch Diagnostics Limited
    • 15.1.20. Leading Biology, Inc.
    • 15.1.21. Liofilchem S.r.l.
    • 15.1.22. Mast Group Ltd.
    • 15.1.23. MP Biomedicals, LLC
    • 15.1.24. Pfizer Inc.
    • 15.1.25. Qiagen N.V.
    • 15.1.26. QuantaMatrix Inc.
    • 15.1.27. Rapid Test Methods Ltd.
    • 15.1.28. Resistell AG
    • 15.1.29. Synoptics Group
    • 15.1.30. Thermo Fisher Scientific Inc.
    • 15.1.31. Zhuhai DL Biotech Co., Ltd.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DYNAMICS
  • FIGURE 7. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 8. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
  • FIGURE 10. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 12. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 14. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 16. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 20. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 25. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 26. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MINIMUM INHIBITORY CONCENTRATION (MIC) STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SUSCEPTIBILITY DISCS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SUSCEPTIBILITY PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 14. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AGAR DILUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DISKS DIFFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ETEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GENOTYPING METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY RAPID AUTOMATION METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIBACTERIAL SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIFUNGAL SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANTIPARASITIC SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MANUAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 283. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 284. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET LICENSE & PRICING